EuroStemCell, launched in March 2010 and funded by the European Commission's Seventh Framework Programme (FP7), unites more than 90 European stem cell and regenerative medicine research labs in a coordinated effort to engage with the public about stem cell science. EuroStemCell is a partnership of scientists, clinicians, ethicists, social scientists and science communicators and works closely with teachers and patient representatives. http://www.eurostemcell.org
Elsevier is a world-leading provider of scientific, technical and medical information products and services. The company works in partnership with the global science and health communities to publish more than 2,000 journals, including The Lancet and Cell, and close to 20,000 book titles, including major reference works from Mosby and Saunders. Elsevier's online solutions include ScienceDirect, Scopus, SciVal, Reaxys, ClinicalKey and Mosby's Suite, which enhance the productivity of science and health professionals, helping research and health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier employs 7,000 people worldwide. The company is part of Reed Elsevier Group PLC, a world leading provider of professional information solutions in the Science, Medical, Legal and Risk and Business sectors, which is jointly owned by Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock Exchange).Media contacts Kyoto University, iCeMS David Hajime Kornhauser, Manager, Overseas Affairs and Public Relations +81-75-753-9748 / 9755 firstname.lastname@example.org EuroStemCell Clare Blackburn, Coordinator Dr. Jan Barfoot, Public Engagement Manager +44-078-1022-3009 +44-131-651-9506 C.Blackburn@ed.ac.uk J.Barfoot@ed.ac.uk Elsevier Ludivine Allagnat Analyst, Global Academic Relations +81-3-5561-5620 email@example.com SOURCE Elsevier